Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

计划入组 324 人 · 首次发布于 2025 年 12 月 8 日

Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

计划入组 90 人 · 首次发布于 2023 年 5 月 22 日

Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer

计划入组 302 人 · 首次发布于 2025 年 5 月 28 日

Tipiracil Hydrochloride/Trifluridine

Trifluridine(Lonsurf, Viroptic)

C₁₀H₁₁F₃N₂O₅ · Rx

Tipiracil(Lonsurf)

C₉H₁₁ClN₄O₂

Trifluridine/Tipiracil Shows DFS Benefit in Resected Stage IV Colorectal Cancer

Irinotecan, Trifluridine/Tipiracil, and Bevacizumab Show Promise in Later-Line Metastatic Colorectal Cancer Treatment

Pooled Safety Analysis Highlights Tolerability of Trifluridine/Tipiracil Plus Bevacizumab in Metastatic Colorectal Cancer